Skip to Main Content

Author Details

Thinzar M Lwin
City of Hope National Medical Center
2011
55
14
PMIDPaper TitleJournal TitlePublished Year
37839102Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.J Surg Res2024
36056196ASO Visual Abstract: Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model.Ann Surg Oncol2023
37845517Fluorescence lifetime of injected indocyanine green as a universal marker of solid tumours in patients.Nat Biomed Eng2023
37540977PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.J Surg Res2023
37320867Colon-cancer liver metastasis is effectively targeted by recombinant methioninase (rMETase) in an orthotopic mouse model.Tissue Cell2023
37121988Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy Era.Ann Surg Oncol2023
37185743Specific Targeting and Labeling of Colonic Polyps in <i>CPC-APC</i> Mice with Mucin 5AC Fluorescent Antibodies: A Model for Detection of Early Colon Cancer.Curr Issues Mol Biol2023
37248378ASO Visual Abstract: Surgical Utilization and Outcomes for Patients with Stage 4 Melanoma in the Modern Immunotherapy Era.Ann Surg Oncol2023
37341873Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.Mol Imaging Biol2023
37269799Robotic Function-Preserving Resection of Gastric Gastrointestinal Stromal Tumor.J Surg Res2023
37225835ASO Author Reflections: The Evolution of Surgery for Patients with Stage IV Melanoma.Ann Surg Oncol2023
36900282The Mucin Family of Proteins: Candidates as Potential Biomarkers for Colon Cancer.Cancers (Basel)2023
36728297Four-Day Robotic Whipple: Early Discharge after Robotic Pancreatoduodenectomy.J Am Coll Surg2023
36057899Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model.Ann Surg Oncol2023
34407918Rapid intraoperative perfusion assessment of parathyroid adenomas with ICG using a wide-field portable hand-held fluorescence imaging system.Am J Surg2022
35625638Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.Biomolecules2022
35715267Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications.Am J Surg2022
35927078Proof of concept of improved fluorescence-guided surgery of colon cancer liver metastasis using color-coded imaging of a tumor-labeling fluorescent antibody and indocyanine green restricted to the adjacent liver segment.Surgery2022
34972700Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.In Vivo2022
35302604First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes.Clin Cancer Res2022
35053365Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.Cells2022
34309885Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.J Surg Oncol2021
33848831A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment.J Surg Res2021
33670740Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery.Biomolecules2021
34944463The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review.Biomolecules2021
34182469A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.In Vivo2021
32370916Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.Surgery2020
33163512Fluorescence-guided hepatobiliary surgery with long and short wavelength fluorophores.Hepatobiliary Surg Nutr2020
32416765The future of tumour-specific fluorescence-guided surgery for pancreatic cancer.Lancet Gastroenterol Hepatol2020
31077946Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.J Surg Res2019
31519565Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.Anticancer Res2019
31254333Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors.J Biomed Opt2019
31366489Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.Anticancer Res2019
31188174RE: "Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection".Ann Surg2019
30953192Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.Arch Gynecol Obstet2019
29191280Rare, Uncommon, and Unusual Complications After Pancreaticoduodenal Resection.Surg Clin North Am2018
30080930Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.J Surg Oncol2018
29857821MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.Tissue Cell2018
30324479ASO Author Reflections: Fluorescent Anti-CEA IR800 for Tumor Labeling.Ann Surg Oncol2018
30647873Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.Oncotarget2018
29768067The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.Expert Rev Anticancer Ther2018
29372363Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.Ann Surg Oncol2018
29623758Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.Cell Cycle2018
29129358Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism.Surgery2018
28011474Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.Anticancer Res2017
28441080Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.Cell Cycle2017
28404944Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.Oncotarget2017
28296559The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.Cell Cycle2017
28468988ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.J Cell Sci2017
29034343Regarding the applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.Transl Gastroenterol Hepatol2017
  • 1 - 50 of 55

Recommended Authors

Sidney Kimmel Cancer Center at Thomas Jefferson University
Career Start Year 2017
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2015
Number of shared co-authors 0
The Second Hospital of Dalian Medical University
Career Start Year 2010
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 2009
Number of shared co-authors 0
Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.
Career Start Year 2008
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Institute of Molecular and Cell Biology
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
University Health Network
Career Start Year 2001
Number of shared co-authors 0
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 0
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 0
University of Fukui.
Career Start Year 1997
Number of shared co-authors 0
Hospital HM Universitario Sanchinarro
Career Start Year 1997
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
University of Cincinnati College of Medicine
Career Start Year 1996
Number of shared co-authors 1
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 1995
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 0
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1990
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Co-authored papers 44
Co-authored papers 38
Center for Surgery and Public Health, Brigham and Women's Hospital
Co-authored papers 3
University of California-Los Angeles
Co-authored papers 2
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 2
University of California-Los Angeles
Co-authored papers 2
university of california san diego
Co-authored papers 2
University of California San Diego
Co-authored papers 2
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 2
Medical University of South Carolina
Co-authored papers 2
University of California San Diego
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Rice University
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers 1
University of California San Diego
Co-authored papers 1